James Hambro & Partners LLP boosted its stake in shares of Synopsys, Inc. (NASDAQ:SNPS - Free Report) by 30.9% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 201,460 shares of the semiconductor company's stock after acquiring an additional 47,527 shares during the quarter. Synopsys accounts for 3.9% of James Hambro & Partners LLP's holdings, making the stock its 16th largest position. James Hambro & Partners LLP owned approximately 0.13% of Synopsys worth $97,725,000 as of its most recent filing with the Securities and Exchange Commission.
Other hedge funds have also bought and sold shares of the company. Hazlett Burt & Watson Inc. grew its holdings in shares of Synopsys by 40.0% in the third quarter. Hazlett Burt & Watson Inc. now owns 70 shares of the semiconductor company's stock valued at $35,000 after purchasing an additional 20 shares in the last quarter. Green Alpha Advisors LLC grew its holdings in shares of Synopsys by 1.7% in the 3rd quarter. Green Alpha Advisors LLC now owns 1,294 shares of the semiconductor company's stock worth $655,000 after acquiring an additional 22 shares during the period. Aptus Capital Advisors LLC grew its holdings in shares of Synopsys by 1.5% during the third quarter. Aptus Capital Advisors LLC now owns 1,447 shares of the semiconductor company's stock worth $733,000 after buying an additional 22 shares in the last quarter. Resurgent Financial Advisors LLC raised its position in shares of Synopsys by 2.8% in the 3rd quarter. Resurgent Financial Advisors LLC now owns 809 shares of the semiconductor company's stock worth $410,000 after buying an additional 22 shares during the period. Finally, Larson Financial Group LLC grew its stake in Synopsys by 6.1% during the third quarter. Larson Financial Group LLC now owns 398 shares of the semiconductor company's stock worth $202,000 after buying an additional 23 shares during the period. Hedge funds and other institutional investors own 85.47% of the company's stock.
Analyst Ratings Changes
A number of brokerages recently commented on SNPS. Loop Capital initiated coverage on Synopsys in a report on Monday, November 11th. They issued a "buy" rating and a $675.00 price target for the company. Mizuho started coverage on Synopsys in a report on Tuesday, October 22nd. They set an "outperform" rating and a $650.00 target price on the stock. Rosenblatt Securities reissued a "buy" rating and issued a $635.00 target price on shares of Synopsys in a report on Wednesday, December 4th. Piper Sandler lowered their price target on shares of Synopsys from $670.00 to $655.00 and set an "overweight" rating for the company in a research report on Friday, December 6th. Finally, Berenberg Bank initiated coverage on Synopsys in a research note on Tuesday, October 15th. They set a "buy" rating and a $660.00 target price on the stock. One research analyst has rated the stock with a hold rating and eleven have issued a buy rating to the company. According to data from MarketBeat.com, Synopsys currently has a consensus rating of "Moderate Buy" and an average price target of $641.82.
Read Our Latest Report on SNPS
Synopsys Price Performance
Shares of NASDAQ:SNPS traded down $35.46 on Monday, hitting $510.73. The company's stock had a trading volume of 1,838,991 shares, compared to its average volume of 1,126,157. The company has a market capitalization of $78.95 billion, a PE ratio of 35.17, a PEG ratio of 3.57 and a beta of 1.12. Synopsys, Inc. has a 1 year low of $457.52 and a 1 year high of $629.38. The company has a 50-day simple moving average of $518.68 and a 200 day simple moving average of $522.91.
Insiders Place Their Bets
In other news, CRO Richard S. Mahoney sold 20,838 shares of the stock in a transaction that occurred on Wednesday, January 15th. The shares were sold at an average price of $506.01, for a total value of $10,544,236.38. Following the transaction, the executive now owns 1,460 shares in the company, valued at $738,774.60. This represents a 93.45 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Company insiders own 0.66% of the company's stock.
Synopsys Profile
(
Free Report)
Synopsys, Inc provides electronic design automation software products used to design and test integrated circuits. It operates in three segments: Design Automation, Design IP, and Software Integrity. The company offers Digital and Custom IC Design solution that provides digital design implementation solutions; Verification solution that offers virtual prototyping, static and formal verification, simulation, emulation, field programmable gate array (FPGA)-based prototyping, and debug solutions; and FPGA design products that are programmed to perform specific functions.
Further Reading
Before you consider Synopsys, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Synopsys wasn't on the list.
While Synopsys currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Which stocks are likely to thrive in today's challenging market? Enter your email address and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
